Veronica Santilli
Overview
Explore the profile of Veronica Santilli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
890
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cotugno N, Sanna M, Amodio D, Morrocchi E, Pighi C, Medri C, et al.
Vaccine
. 2025 Feb;
49:126778.
PMID: 39947073
Background: Whereas several studies have demonstrated the long-term immunogenicity of BNT162b2 vaccine in healthy adults, little evidence was provided in vulnerable populations (VPs) with generally low ability to respond to...
2.
Olivieri G, Amodio D, Manno E, Santilli V, Cotugno N, Palma P
Vaccine
. 2025 Feb;
51:126853.
PMID: 39946827
The COVID-19 pandemic has significantly impacted immunocompromised patients, particularly those with inborn errors of immunity (IEI), transplant recipients, hematologic malignancies, and those undergoing treatment with immunosuppressive biologics and medications. These...
3.
Moschese V, Graziani S, Spadea A, DAmore M, Mosco R, Ciampini S, et al.
Vaccine
. 2024 Nov;
42(26):126466.
PMID: 39486353
Background: An equitable immunization coverage to "leave no one behind" is one of the World Health Organization Sustainable Development Goals. However, disparities in vaccination coverage exist. The present study aims...
4.
Montin D, Santilli V, Beni A, Costagliola G, Martire B, Mastrototaro M, et al.
Front Immunol
. 2024 Oct;
15:1436108.
PMID: 39421749
The emergence of vaccinomics and system vaccinology represents a transformative shift in immunization strategies, advocating for personalized vaccines tailored to individual genetic and immunological profiles. Integrating insights from genomics, transcriptomics,...
5.
Moschese V, Montin D, Ottaviano G, Sgrulletti M, Beni A, Costagliola G, et al.
Pediatr Allergy Immunol
. 2024 Sep;
35(9):e14236.
PMID: 39244712
Hypersensitivity reactions represent one of the most common causes of hesitancy for adherence to national vaccination programs. The majority of hypersensitivity reactions after vaccination are mild, and anaphylaxis is reported...
6.
Franzese E, Rotulo G, Amodio D, Manno E, Zangari P, Rivalta B, et al.
Pediatr Infect Dis J
. 2024 Sep;
PMID: 39230260
No abstract available.
7.
Zangari P, Giancotta C, Pacillo L, Colantoni N, Leone F, Amodio D, et al.
Pediatr Allergy Immunol
. 2024 Aug;
35(8):e14215.
PMID: 39105363
No abstract available.
8.
Cotugno N, Neri A, Sanna M, Santilli V, Manno E, Pascucci G, et al.
JCI Insight
. 2024 May;
9(10).
PMID: 38775152
Children with perinatally acquired HIV (PHIV) have special vaccination needs, as they make suboptimal immune responses. Here, we evaluated safety and immunogenicity of 2 doses of 4-component group B meningococcal...
9.
Rivalta B, Zangari P, Pacillo L, Manno E, Santilli V, Rotulo G, et al.
Pediatr Blood Cancer
. 2024 Apr;
71(7):e31019.
PMID: 38616383
No abstract available.
10.
Rotulo G, Ceglie G, Candino A, Merola A, Profeti E, Giancotta C, et al.
Pediatr Infect Dis J
. 2023 Sep;
42(11):e403-e406.
PMID: 37773636
Severe acute respiratory syndrome coronavirus 2 infection in children with autoimmune neutropenia may be a cause for concern. In this retrospective study, none of the 24 autoimmune neutropenia cases manifested...